NCT04437537View on ClinicalTrials.gov

Pilot Study of PHOENIX Wound Matrix® Impact on Chronic DFU Wound Microbiome

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

August 1, 2025

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Bioresorbable 3D electrospun synthetic matrix

All participants in this study will receive PHOENIX Wound Matrix® in addition to the SOC treatment for their chronic DFU.

Trial Locations (1)

18067

RECRUITING

PA Foot & Ankle Associates, Northampton

All Listed Sponsors
collaborator

Simon Tabchi DPM, PA Foot & Ankle Associates

UNKNOWN

collaborator

Lindsay Kalan PhD, Kalan Lab, McMaster University

UNKNOWN

lead

RenovoDerm

INDUSTRY